Some researchers seek to establish a single abnormal result on a set of biomarker-based tests as sufficient to diagnose the ...

Hyperfine, Inc. announced the presentation of additional research data and images using the Swoop® system to image patients ...

Researchers have used advanced brain-imaging techniques to determine whether language skills physically alters the brain's ...

Amyloid alone does not confirm that Alzheimer's disease is progressing rapidly. Here's what people need to know about the ...

With Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla launching onto the market, the 2024 Clinical Trials of Alzheimer’s ...

The human brain's glymphatic system, instrumental in removing toxins, has been visualized in living people through MRI ...

Alzheimer's disease might damage the brain in two distinct ... according to sophisticated brain scans. Advertisement "The results fundamentally alter scientists' understanding of how Alzheimer's ...

In a small early trial using a transcranial magnetic stimulation procedure, scientists were able to target a key brain ...

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

As the world of neurodegenerative disease drug development continues to be roiled by controversies, one company has taken a ...

"The results fundamentally alter scientists' understanding of how Alzheimer's harms the brain," researchers say.

Roche put forward new data on two of its upcoming, non-invasive blood tests designed to help rule out a diagnosis of ...